pyridinolcarbamate has been researched along with Brain Ischemia in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le Poncin-Lafitte, M | 1 |
| Grosdemouge, C | 1 |
| Rapin, JR | 1 |
1 other study available for pyridinolcarbamate and Brain Ischemia
| Article | Year |
|---|---|
[Drug protection of cerebral metabolism and behavioral activity after an acute ischemic stroke].
Topics: Acute Disease; Animals; Behavior, Animal; Brain Ischemia; Cerebral Infarction; Chloral Hydrate; Ener | 1982 |